These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 4034863)

  • 1. Are there state-dependent markers in schizophrenia?
    van Kammen DP; Rosen J; Peters J; Fields R; van Kammen WB
    Psychopharmacol Bull; 1985; 21(3):497-502. PubMed ID: 4034863
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Biol Psychiatry; 1983 Aug; 18(8):875-85. PubMed ID: 6137249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings.
    Szymanski S; Lieberman J; Pollack S; Safferman A; Munne R; Umbricht D; Kane J; Kronig M; Chakos M; Cooper T
    Biol Psychiatry; 1995 Jan; 37(1):52-5. PubMed ID: 7893860
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients.
    Müller-Spahn F; Modell S; Ackenheil M; Brachner A; Kurtz G
    J Psychiatr Res; 1998; 32(5):265-71. PubMed ID: 9789204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic tests in psychiatry.
    Sternberg DE
    Psychiatr Clin North Am; 1984 Sep; 7(3):639-50. PubMed ID: 6435102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R; Hirschowitz J; Zemlan F; Hitzemann B; Garver D
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone response to apomorphine.
    Ferrier IN; Johnstone EC; Crow TJ
    Arch Gen Psychiatry; 1987 Jan; 44(1):93-4. PubMed ID: 3800586
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological markers for endogenous depression in series and parallel.
    Feinberg M; Carroll BJ
    Biol Psychiatry; 1984 Jan; 19(1):3-11. PubMed ID: 6704459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of response to clozapine.
    Lieberman JA; Kane JM; Safferman AZ; Pollack S; Howard A; Szymanski S; Masiar SJ; Kronig MH; Cooper T; Novacenko H
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():126-8. PubMed ID: 7961556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical method and its modification for differential diagnosis of neuroses and neurosis-like conditions].
    Poliakov VD
    Sov Med; 1970 Nov; 33(11):38-40. PubMed ID: 5521962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological markers in schizophrenia].
    Lembreghts M; Ansseau M
    Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prolactin response in schizophrenic, schizophreniform, and manic disorders.
    Hitzemann R; Hirschowitz J; Hitzemann B; Garver D
    Biol Psychiatry; 1984 Jun; 19(6):913-8. PubMed ID: 6743725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
    Nemtsov AV; Kalinin VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1232-41. PubMed ID: 6171962
    [No Abstract]   [Full Text] [Related]  

  • 16. Blunted growth hormone response is associated with early relapse in alcohol-dependent patients.
    Heinz A; Dettling M; Kuhn S; Dufeu P; Gräf KJ; Kürten I; Rommelspacher H; Schmidt IG
    Alcohol Clin Exp Res; 1995 Feb; 19(1):62-5. PubMed ID: 7771665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholics with reduced dopamine D2 receptor function possess normal platelet monoamine oxidase activity.
    Balldin J; Berggren U; Lindstedt G; Oreland L
    Alcohol Alcohol; 1994 Nov; 29(6):659-61. PubMed ID: 7695780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The schizophrenia syndrome. Examples of biological tools for subclassification.
    Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV
    J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pirenzepine on apomorphine-induced growth hormone secretion in man.
    Massara F; Tangolo D; Demislis K; Goffi S; Bertagna A; Molinatti GM
    Panminerva Med; 1984; 26(3):167-9. PubMed ID: 6549208
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
    Goodnick PJ; Meltzer HY
    J Clin Psychopharmacol; 1983 Aug; 3(4):239-43. PubMed ID: 6411776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.